Results 231 to 240 of about 24,216,259 (358)

Dynamic response analysis of concrete box subgrade under double-line heavy-haul railway. [PDF]

PLoS One
Liu J, Jin Y, Zhao B, Qin A, Zhao M, Guo J, Guo E.   +6 more
europepmc   +1 more source

A Simple General Approach to Inference About the Tail of a Distribution

, 1975
B. Hill
semanticscholar   +1 more source

Low-Dimensional Reconciliation for Continuous-Variable Quantum Key Distribution

, 2018
László Gyöngyösi, Sándor Imre
openalex   +1 more source

Distributing Health

The American Journal of Bioethics, 2012
openaire   +5 more sources

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Accurate modelling of intrabeam scattering and its impact on photoinjectors for free-electron lasers. [PDF]

Sci Rep
Lucas TG, Craievich P, Prat E, Reiche S, Gjonaj E.   +4 more
europepmc   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Most Neuroscience Data Is Not Normally Distributed: Analyzing Your Data in a Non-normal World. [PDF]

eNeuro
Malek-Ahmadi M, Reed AM, Guan DX.
europepmc   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

Sex-divergent anatomic system concordance in second primary malignant neoplasms: a large-scale analysis. [PDF]

Front Oncol
Liu Y, Shi L, Han W, Duan X, Lv P, Li N, Zhang X, Liu J, Zhao J.   +8 more
europepmc   +1 more source